<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Tehran University of Medical Sciences</PublisherName>
				<JournalTitle>Nanomedicine Research Journal</JournalTitle>
				<Issn>2476-3489</Issn>
				<Volume>11</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Synthesis of Silibinin-Loaded Cellulose Nanocrystals Modified with Cetyltrimethylammonium Bromide (CTAB) and Investigation of its Cytotoxic Effects on Mcf-7 Breast Cancer Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>167</FirstPage>
			<LastPage>176</LastPage>
			<ELocationID EIdType="pii">741399</ELocationID>
			
<ELocationID EIdType="doi">10.22034/nmrj.2026.02.007</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Nahid</FirstName>
					<LastName>Irani</LastName>
<Affiliation>Department of Biology, Ma.C., Islamic Azad University, Mashhad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Yashar</FirstName>
					<LastName>Gholitabar Omrani</LastName>
<Affiliation>Department of Biology, Ma.C., Islamic Azad University, Mashhad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Masoud</FirstName>
					<LastName>Homayuni-Tabrizi</LastName>
<Affiliation>Department of Biology, Ma.C., Islamic Azad University, Mashhad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Es-haghi</LastName>
<Affiliation>Department of Biology, Ma.C., Islamic Azad University, Mashhad, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5292-6161</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Anticancer drug delivery remains a challenge of paramount importance in oncology. Recently, cellulose nanocrystals (CNC) have been used to optimize drug dispersion and loading efficiency. The goal of this research is to modify CNC with cetyltrimethylammonium bromide (CTAB) and loading silibinin into it, to deliver the silibinin to breast cancer cells.  Nanoparticles were synthesized and its surface modify by CTAB then, silibinin was loaded into it. SIL-CNC-CTAB were analyzed using special techniques for nanoparticle analysis such as dynamic light scattering (DLS), transmission electron microscopy (TEM), fourier transform infrared spectroscopy (FTIR) and zeta potential measurement. Anticancer effects were evaluated through the MTT assay. Apoptosis detection was evaluated by acridine orange/propidium iodide (AO/PI) staining.  The obtain results showed a hydrodynamic diameter of NP was 335.65 nm with a poly dispersity index (PDI) of 0.35. Zeta potential of was -26.66±6.32 mV. Encapsulation efficiency determined 83.8% of silibinin loaded on CNC-CTAB. Breast cancer MCF-7 cells exposed to silibinin-loaded CTAB-modified CNCs revealed significant toxicity with an IC50 value of 107 µg/mL and promotion of apoptotic changes confirmed by AO/PI analysis. According to the data of the present study, silibinin-loaded CTAB-modified CNCs could prevent the progress and proliferation of MCF-7 breast cancer cells.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Cellulose nanocrystals</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">CTAB</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Silibinin</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.nanomedicine-rj.com/article_741399_830429c229ddfb8131ef4680d1bc2dc9.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
